Last $191.90 USD
Change Today +2.69 / 1.42%
Volume 656.1K
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

5200 Illumina Way

San Diego, CA 92122

United States

Phone: 858-202-4500

Fax: 858-202-4766

censes to, 402 issued U.S. patents and 383 pending U.S. patent applications, including 22 allowed applications that have not yet issued as patents. Its issued patents have terms that expire between 2014 and 2032. Research and Development The company’s research and development expenses were $276.7 million for the year ended December 29, 2013. Significant Events In August 2014, Illumina, Inc. announced it has formed collaborative partnerships with leading pharmaceutical companies to develop a universal next-generation sequencing (NGS)-based oncology test system. In August 2014, AstraZeneca has entered into a collaboration with Illumina Inc. to develop its next generation sequencing, or NGS, platform for companion diagnostic tests applicable across AstraZeneca's oncology portfolio. In October 2014, Reprogenetics Inc. announced that the company has signed a collaboration agreement with Illumina as its preferred partner for the research and development of in-vitro fertilization (IVF)-related sequencing technologies. History Illumina, Inc. was founded in 1998. The company was incorporated in California in 1998 and reincorporated in Delaware in 2000.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ILMN:US $191.90 USD +2.69

ILMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Avago Technologies Ltd $93.78 USD +2.63
Becton Dickinson and Co $141.26 USD +6.53
Dr Reddy's Laboratories Ltd 3,606 INR -4.65
Sigma-Aldrich Corp $136.53 USD -0.02
Waters Corp $115.87 USD +0.06
View Industry Companies
 

Industry Analysis

ILMN

Industry Average

Valuation ILMN Industry Range
Price/Earnings 99.6x
Price/Sales 15.4x
Price/Book 21.1x
Price/Cash Flow 84.3x
TEV/Sales 14.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILLUMINA INC, please visit www.illumina.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.